Leanne Peiser

1.9k total citations
18 papers, 1.3k citations indexed

About

Leanne Peiser is a scholar working on Immunology, Epidemiology and Microbiology. According to data from OpenAlex, Leanne Peiser has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Epidemiology and 5 papers in Microbiology. Recurrent topics in Leanne Peiser's work include Immune Response and Inflammation (9 papers), Bacterial Infections and Vaccines (5 papers) and CAR-T cell therapy research (4 papers). Leanne Peiser is often cited by papers focused on Immune Response and Inflammation (9 papers), Bacterial Infections and Vaccines (5 papers) and CAR-T cell therapy research (4 papers). Leanne Peiser collaborates with scholars based in United Kingdom, United States and Japan. Leanne Peiser's co-authors include Siamon Gordon, Subhankar Mukhopadhyay, Tatsuhiko Kodama, Peter J. Gough, E. Richard Moxon, Katherine Makepeace, Menno P.J. de Winther, Michael Hollinshead, Philip A. Coull and Joyce S. Plested and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Leanne Peiser

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leanne Peiser United Kingdom	12	805	376	311	121	102	18	1.3k
Kiyotoshi Mori Japan	6	881 1.1×	280 0.7×	190 0.6×	76 0.6×	42 0.4×	10	1.2k
Young Hee Ryu South Korea	11	586 0.7×	418 1.1×	225 0.7×	166 1.4×	37 0.4×	13	1.1k
Keith Gorden United States	11	1.0k 1.3×	242 0.6×	250 0.8×	104 0.9×	39 0.4×	28	1.3k
Mark Rutz Germany	9	1.2k 1.5×	418 1.1×	242 0.8×	209 1.7×	24 0.2×	11	1.6k
Nadra Nilsen Norway	12	1.6k 2.0×	525 1.4×	358 1.2×	241 2.0×	26 0.3×	14	2.0k
Jan‐Michel Otte Germany	18	772 1.0×	380 1.0×	168 0.5×	142 1.2×	84 0.8×	29	1.6k
Krishnamurthy Malathi United States	20	844 1.0×	839 2.2×	256 0.8×	39 0.3×	48 0.5×	29	1.6k
Jackie C. Timans France	9	1.6k 2.0×	665 1.8×	271 0.9×	278 2.3×	30 0.3×	10	2.2k
Şefik Ş. Alkan United States	23	1.7k 2.2×	518 1.4×	555 1.8×	148 1.2×	54 0.5×	44	2.8k

Countries citing papers authored by Leanne Peiser

Since Specialization

Citations

This map shows the geographic impact of Leanne Peiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Peiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Peiser more than expected).

Fields of papers citing papers by Leanne Peiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leanne Peiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Peiser. The network helps show where Leanne Peiser may publish in the future.

Co-authorship network of co-authors of Leanne Peiser

This figure shows the co-authorship network connecting the top 25 collaborators of Leanne Peiser. A scholar is included among the top collaborators of Leanne Peiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leanne Peiser. Leanne Peiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wierda, William G., David G. Maloney, Saad S. Kenderian, et al.. (2024). CLL-184 Characteristics Associated With Response to Lisocabtagene Maraleucel (liso-cel) in Patients With R/R CLL/SLL: Exploratory Analyses From the Phase 1/2 TRANSCEND CLL 004 Study. Clinical Lymphoma Myeloma & Leukemia. 24. S346–S346. 3 indexed citations

Wierda, William G., David G. Maloney, Saad S. Kenderian, et al.. (2024). Characteristics Associated With Response to Lisocabtagene Maraleucel (liso-cel) in Patients With R/R CLL/SLL: Exploratory Analyses From the Phase 1/2 TRANSCEND CLL 004 Study. Clinical Lymphoma Myeloma & Leukemia. 24. S180–S180. 1 indexed citations

Stepan, Lara, Sahar Ansari, Ethan Thompson, et al.. (2023). Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study. Blood. 142(Supplement 1). 225–225. 3 indexed citations

OGASAWARA, K., James Lymp, Timothy R. Mack, et al.. (2022). In Vivo Cellular Expansion of Lisocabtagene Maraleucel and Association With Efficacy and Safety in Relapsed/Refractory Large B‐Cell Lymphoma. Clinical Pharmacology & Therapeutics. 112(1). 81–89. 14 indexed citations

Thorpe, Jerill, Yue Jiang, Julie Rytlewski, et al.. (2021). Characteristics of Post-Infusion Chimeric Antigen Receptor (CAR) T Cells and Endogenous T Cells Associated with Early and Long-Term Response in Lisocabtagene Maraleucel (liso-cel)-Treated Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL). Blood. 138(Supplement 1). 3834–3834. 1 indexed citations

Thorpe, Jerill, Julie Rytlewski, Heidi H. Gillenwater, et al.. (2021). 449 Concurrent ibrutinib enhances T cell function in patients with chronic lymphocytic leukemia (CLL) treated with lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T cell therapy. SHILAP Revista de lepidopterología. A477–A477. 2 indexed citations

Amin, Oliver E., Emily J. Colbeck, Stéphane Daffis, et al.. (2020). Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators. Hepatology. 74(1). 55–71. 69 indexed citations

Niu, Congrong, Christine M. Livingston, Li Li, et al.. (2017). The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. PLoS ONE. 12(1). e0169648–e0169648. 114 indexed citations

Plüddemann, Annette, Claudine Neyen, Siamon Gordon, & Leanne Peiser. (2007). A sensitive solid-phase assay for identification of class A macrophage scavenger receptor ligands using cell lysate. Journal of Immunological Methods. 329(1-2). 167–175. 11 indexed citations

10.

Yona, Simon, Sigrid E.M. Heinsbroek, Leanne Peiser, et al.. (2006). Impaired phagocytic mechanism in annexin 1 null macrophages. British Journal of Pharmacology. 148(4). 469–477. 47 indexed citations

11.

Peiser, Leanne, Katherine Makepeace, Annette Plüddemann, et al.. (2006). Identification ofNeisseria meningitidisNonlipopolysaccharide Ligands for Class A Macrophage Scavenger Receptor by Using a Novel Assay. Infection and Immunity. 74(9). 5191–5199. 47 indexed citations

12.

Mukhopadhyay, Subhankar, Yunying Chen, Marko Sankala, et al.. (2006). MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis. European Journal of Immunology. 36(4). 940–949. 66 indexed citations

13.

Szabó, Rita, Leanne Peiser, Annette Plüddemann, et al.. (2005). Uptake of Branched Polypeptides with Poly[l-Lys] Backbone by Bone-Marrow Culture-Derived Murine Macrophages: The Role of the Class A Scavenger Receptor. Bioconjugate Chemistry. 16(6). 1442–1450. 17 indexed citations

14.

Mukhopadhyay, Subhankar, Leanne Peiser, & Siamon Gordon. (2004). Activation of murine macrophages byNeisseria meningitidisand IFN-γ in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype. Journal of Leukocyte Biology. 76(3). 577–584. 46 indexed citations

15.

Peiser, Leanne, Subhankar Mukhopadhyay, & Siamon Gordon. (2002). Scavenger receptors in innate immunity. Current Opinion in Immunology. 14(1). 123–128. 371 indexed citations

16.

Peiser, Leanne, Menno P.J. de Winther, Katherine Makepeace, et al.. (2002). The Class A Macrophage Scavenger Receptor Is a Major Pattern Recognition Receptor for Neisseria meningitidis Which Is Independent of Lipopolysaccharide and Not Required for Secretory Responses. Infection and Immunity. 70(10). 5346–5354. 114 indexed citations

17.

Peiser, Leanne & Siamon Gordon. (2001). The function of scavenger receptorsexpressed by macrophages and their rolein the regulation of inflammation. Microbes and Infection. 3(2). 149–159. 177 indexed citations

18.

Peiser, Leanne, Peter J. Gough, Tatsuhiko Kodama, & Siamon Gordon. (2000). Macrophage Class A Scavenger Receptor-Mediated Phagocytosis ofEscherichia coli: Role of Cell Heterogeneity, Microbial Strain, and Culture Conditions In Vitro. Infection and Immunity. 68(4). 1953–1963. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact